Silver Book Fact

HAI Annual Cost

Healthcare-associated infections in US hospitals cost $96–$147 billion annually.

Marchetti A, Rossiter R. Economic Burden of Healthcare-associated Infection in US Acute Care Hospitals: Societal perspective. Journal of Medical Economics. 2013; 16(12): 1399-1404. http://www.tandfonline.com/doi/abs/10.3111/13696998.2013.842922?journalCode=ijme20#.Vi6J8TZdHIU

Reference

Title
Economic Burden of Healthcare-associated Infection in US Acute Care Hospitals: Societal perspective
Publication
Journal of Medical Economics
Publication Date
2013
Authors
Marchetti A, Rossiter R
Volume & Issue
Volume 16, Issue 12
Pages
1399-1404
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Hospital stays longer when HAIs involved
    The average length of hospital stays are 19 days longer with healthcare-associated infections than without (24.4 days versus 5.2 days).  
  • 1 in 4 inpatient pneumonia hospitalizations due to HAIs
    In one study, one in four inpatient pneumonia hospitalizations were from health-care-associated pneumonia.  
  • >20% of drug-resistant pneumonia in nursing homes
    More than 20% of drug-resistant cases of pneumonia in 2010 occurred in nursing home residents.  
  • Drug-resistant MRSA expensive to treat
    As an example, the median treatment cost for drug-resistant MRSA patients over a 6-month period was 118% higher than the cost of treating drug-susceptible MRSA strains.  
  • Drug resistant infections cost $16.6 – $26 billion to US healthcare system annually
    Drug-resistant infections cost the U.S. healthcare system between $16.6 and $26 billion in extra costs each year.